5N25
Crystal structure of human carbonic anhydrase II in complex with the inhibitor 4-Pyridin-3-yl-benzenesulfonamide
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ESRF BEAMLINE BM30A |
| Synchrotron site | ESRF |
| Beamline | BM30A |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2015-04-10 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 0.979783 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 42.389, 41.188, 71.794 |
| Unit cell angles | 90.00, 104.41, 90.00 |
Refinement procedure
| Resolution | 30.000 - 1.400 |
| R-factor | 0.1735 |
| Rwork | 0.172 |
| R-free | 0.19910 |
| Structure solution method | FOURIER SYNTHESIS |
| Starting model (for MR) | 4fik |
| RMSD bond length | 0.006 |
| RMSD bond angle | 1.196 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Refinement software | REFMAC (5.8.0073) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 30.000 | 30.000 | 1.490 |
| High resolution limit [Å] | 1.400 | 4.190 | 1.400 |
| Rmerge | 0.078 | 0.031 | 0.712 |
| Rmeas | 0.095 | 0.038 | 0.862 |
| Total number of observations | 139982 | ||
| Number of reflections | 45430 | 1786 | 7131 |
| <I/σ(I)> | 10.76 | 31.9 | 1.65 |
| Completeness [%] | 95.9 | 95.7 | 94.1 |
| Redundancy | 3.081 | 2.964 | 3.103 |
| CC(1/2) | 0.997 | 0.997 | 0.577 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION | 8 | 296 | 1.5 M sodium citrate, Tris 50 mM |






